-
www.ahrq.gov/sites/default/files/wysiwyg/topics/dxsafety-current-state.pdf
January 01, 2024 - Current State of Diagnostic Safety: Implications for Research, Practice, and Policy - Issue Brief
PATIENT
SAFETY
e
Issue Brief 16
Current State of Diagnostic Safety:
Implications for Research, Practice,
and Policy
This page intentionally left blank.
e
Issue Brief 16
Current State of Diagnostic Safety:
…
-
www.uspreventiveservicestaskforce.org/Home/GetFile/1/16768/ovarian-cancer-final-evid-review/pdf
February 01, 2018 - Screening for Ovarian Cancer: An Updated Evidence Review for the USPSTF
Evidence Synthesis
Number 157
Screening for Ovarian Cancer: An Updated Evidence
Review for the U.S. Preventive Services Task Force
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Service…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2sssC_CV4u5DY_rgjC-FMd
February 01, 2018 - Screening for Ovarian Cancer: An Updated Evidence Review for the USPSTF
Evidence Synthesis
Number 157
Screening for Ovarian Cancer: An Updated Evidence
Review for the U.S. Preventive Services Task Force
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Service…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
October 25, 2010 - Future Research Needs Document
Future Research Needs To Reduce the Risk of Primary Breast Cancer in Women was available
for public comment from September 29, 2010, to October 25, 2010. In response to questions and
suggestions received, revisions were made in this version to clarify that no incentives were
offere…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
October 25, 2010 - Future Research Needs Document
Future Research Needs To Reduce the Risk of Primary Breast Cancer in Women was available
for public comment from September 29, 2010, to October 25, 2010. In response to questions and
suggestions received, revisions were made in this version to clarify that no incentives were
offere…
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2020-Compendium-TechDoc-rev.pdf
January 01, 2020 - Compendium of U.S. Health Systems, 2020, Technical Documentation
Comparative Health System Performance Initiative:
Compendium of U.S. Health Systems, 2020, Technical
Documentation
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
5600 Fishers Lane
R…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
March 01, 2013 - Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons
Methods Research Report
Case Study Comparing Bayesian and
Frequentist Approaches for Multiple Treatment
Comparisons
Methods Research Report
Case Study Comparing Bayesian and Frequ…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
March 01, 2013 - Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons
Methods Research Report
Case Study Comparing Bayesian and
Frequentist Approaches for Multiple Treatment
Comparisons
Methods Research Report
Case Study Comparing Bayesian and Frequ…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments
Rapid Evidence Product
Adverse Events Associated With
COVID-19 Pharmaceutical Treatments
Background and Purpose
The purpose of this rapid review is to determine if COVID treatments authorized for
emergency use…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments
Rapid Evidence Product
Adverse Events Associated With
COVID-19 Pharmaceutical Treatments
Background and Purpose
The purpose of this rapid review is to determine if COVID treatments authorized for
emergency use…